Plasmid-mediated macrolide resistance among rapidly growing mycobacteria in Japan

Takeshi Komine1, Panuwat Sathianpitayakul2,3, Nobuya Sakagami4

  • 1Leprosy Research Center, National Institute of Infectious Diseases, Japan Institute for Health Security, Higashimurayama, Tokyo, Japan.

Abstract

Insights

Plasmids carrying the erm(55) gene, conferring inducible macrolide resistance in rapidly growing mycobacteria (RGM), were found in Japan. This study characterized these erm(55)-carrying plasmids in clinical RGM isolates.

Area of Science:

  • Microbiology
  • Genetics
  • Antimicrobial Resistance

Background:

  • Plasmids encoding the 23S rRNA methylase gene erm(55) confer inducible macrolide resistance in rapidly growing mycobacteria (RGM).
  • Previous reports of erm(55)-carrying plasmids are primarily from the United States.

Purpose of the Study:

  • To determine the prevalence of erm(55)-carrying plasmids in clinically isolated RGM strains in Japan.
  • To characterize the genomic features of these plasmids.

Main Methods:

  • Screening of 607 RGM clinical isolates (2019-2023) using PCR for erm(55).
  • Minimum inhibitory concentration testing for clarithromycin.
  • Whole-plasmid genome sequencing and comparative genomic analyses.

Main Results:

  • A prevalence of 0.8% was observed, with five strains (Mycobacterium murale, M. obuense, M. chelonae) harboring erm(55)-carrying plasmids.
  • Plasmids ranged from 126,187 to 170,220 bp and showed high sequence similarity.
  • Conserved conjugation-related genes were identified, alongside variable regions with insertion sequences and mercury resistance genes.

Conclusions:

  • erm(55)-carrying plasmids were detected in Japanese RGM isolates, indicating their presence beyond the US.
  • These plasmids confer inducible macrolide resistance in RGM.
  • Further research is needed to understand the broader distribution and functional roles of these plasmids in mycobacteria.

Related Concept Videos

Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
115
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
43
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
2.0K